ClinicalTrials.Veeva

Menu

Safety and Feasibility of the ELIOS System in POAG Patients

E

Elios Vision

Status

Enrolling

Conditions

Glaucoma, Primary Open Angle

Treatments

Device: ELIOS Procedure

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Evaluation of the safety and effectiveness of the ELIOS System procedure to reduce intraocular pressure (IOP) in adult subjects with mild to moderate primary open-angle glaucoma (POAG)

Enrollment

65 estimated patients

Sex

All

Ages

45+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of mild to moderate POAG
  • Medicated IOP of <=24 mmHg
  • Shaffer angle grade of III or IV
  • CD ratio <=0.8
  • At least 45 years old

Exclusion criteria

  • Closed-angle and secondary glaucomas
  • Prior incisional glaucoma surgery, intraocular surgery, or corneal surgery
  • Cannot undergo medication washout in the study eye
  • Diagnosis of degenerative visual disorders Non-study eye with BCVA worse than 20/80 Known corticosteroid responder Pregnant or nursing women; or women of childbearing potential not using medically acceptable birth control

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

65 participants in 1 patient group

ELIOS Procedure
Experimental group
Description:
ELIOS Procedure
Treatment:
Device: ELIOS Procedure

Trial contacts and locations

5

Loading...

Central trial contact

Rupali Nangia

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems